Author:
Boin Francesco,Wigley Fredrick
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Hunzelmann, N. et al. High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy. Arthritis Res. Ther. 11, R30 (2009).
2. Kowal-Bielecka, O. et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann. Rheum. Dis. 68, 620–628 (2009).
3. Boin, F. & Rosen, A. Autoimmunity in systemic sclerosis: current concepts. Curr. Rheumatol. Rep. 9, 165–172 (2007).
4. Bérezné, A. et al. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study. J. Rheumatol. 35, 1064–1072 (2008).
5. Tashkin, D. P. et al. Cyclophosphamide versus placebo in scleroderma lung disease. N. Engl. J. Med. 354, 2655–2666 (2006).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献